PortViewPortView
Avid Bioservices logo

Avid Bioservices (CDMO) Stock Analysis

NASDAQHealthcareBiotechnology

$12.49+0.00%
1-year price historyRange $6.09 – $12.49
52-week range$12.49
$5.90$12.51

What Avid Bioservices does

Avid Bioservices, Inc. operates as a Contract Development and Manufacturing Organization (CDMO), specializing in the development and CGMP-compliant production of biopharmaceutical drug substances. Their core expertise lies in compounds derived from mammalian cell culture, providing both clinical and commercial scale manufacturing solutions. The company is proficient in producing critical therapeutics such as monoclonal antibodies and recombinant proteins. Beyond manufacturing, their comprehensive service portfolio encompasses CGMP manufacturing for drug substances, bulk packaging, rigorous release and stability testing, and essential regulatory submission and support. Additionally, Avid Bioservices offers a range of process development services, including the optimization of upstream and downstream processes, alongside the development, testing, and characterization of analytical methods. Avid Bioservices primarily serves clients within the biotechnology and biopharmaceutical industries. The company, which was originally incorporated in 1981, was known as Peregrine Pharmaceuticals, Inc. before officially rebranding to Avid Bioservices, Inc. in January 2018. Its corporate headquarters are situated in Tustin, California.

Key metrics

Market cap
$798.90M
P/E (TTM)
-5.18
EPS (TTM)
$-2.41
Beta
1.41
Dividend yield
0.00%
Revenue / share
$2.21
50-day avg
$12.36
200-day avg
$10.25
52-week high
$12.51
52-week low
$5.90
CEO
Nicholas Stewart Green MBA

ETFs linked to CDMO

Broad-market and Healthcare sector ETFs an investor holding Avid Bioservices is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CDMO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CDMO in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Avid Bioservices?
Avid Bioservices trades under the ticker CDMO on NASDAQ.
Which exchange is CDMO listed on?
CDMO is listed on NASDAQ.
What sector does Avid Bioservices operate in?
Avid Bioservices is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CDMO in a portfolio?
PortView shows CDMO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.